# Loews Corp: financial statements, quarterly

L · NYSE · CIK 60086 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/l.md) · [Financials](/companies/l/financials.md) · [Filings](/companies/l/filings.md) · [Insiders](/companies/l/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/l/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [537](/filings/0000060086-24-000196.md) | [700 d](/filings/0000060086-26-000008.md) | [710](/filings/0000060086-25-000091.md) | [711](/filings/0000060086-25-000166.md) | [683](/filings/0000060086-25-000181.md) | [789 d](/filings/0000060086-26-000008.md) | [846](/filings/0000060086-26-000032.md) | [769](/filings/0000060086-26-000047.md) | [732](/filings/0000060086-25-000181.md) | [827 d](/filings/0000060086-26-000008.md) | [858](/filings/0000060086-26-000032.md) | [828](/filings/0000060086-26-000047.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [94.0](/filings/0000060086-24-000196.md) | [96.0 d](/filings/0000060086-26-000008.md) | [103](/filings/0000060086-25-000091.md) | [114](/filings/0000060086-25-000166.md) | [114](/filings/0000060086-25-000181.md) | [110 d](/filings/0000060086-26-000008.md) | [105](/filings/0000060086-26-000032.md) | [107](/filings/0000060086-26-000047.md) | [112](/filings/0000060086-25-000181.md) | [113 d](/filings/0000060086-26-000008.md) | [113](/filings/0000060086-26-000032.md) | [103](/filings/0000060086-26-000047.md) |
| Income tax | $m | [80.0](/filings/0000060086-24-000196.md) | [136 d](/filings/0000060086-26-000008.md) | [144](/filings/0000060086-25-000091.md) | [112](/filings/0000060086-25-000166.md) | [125](/filings/0000060086-25-000181.md) | [(1.0) d](/filings/0000060086-26-000008.md) | [122](/filings/0000060086-26-000032.md) | [123](/filings/0000060086-26-000047.md) | [153](/filings/0000060086-25-000181.md) | [113 d](/filings/0000060086-26-000008.md) | [109](/filings/0000060086-26-000032.md) | [141](/filings/0000060086-26-000047.md) |
| Net income | $m | [253](/filings/0000060086-24-000196.md) | [446 d](/filings/0000060086-26-000008.md) | [457](/filings/0000060086-25-000091.md) | [369](/filings/0000060086-25-000166.md) | [401](/filings/0000060086-25-000181.md) | [187 d](/filings/0000060086-26-000008.md) | [370](/filings/0000060086-26-000032.md) | [391](/filings/0000060086-26-000047.md) | [504](/filings/0000060086-25-000181.md) | [402 d](/filings/0000060086-26-000008.md) | [337](/filings/0000060086-26-000032.md) | [444](/filings/0000060086-26-000047.md) |
| Diluted EPS | $ per share | [1.12](/filings/0000060086-24-000196.md) | not reported | [2.05](/filings/0000060086-25-000091.md) | [1.67](/filings/0000060086-25-000166.md) | [1.82](/filings/0000060086-25-000181.md) | not reported | [1.74](/filings/0000060086-26-000032.md) | [1.87](/filings/0000060086-26-000047.md) | [2.43](/filings/0000060086-25-000181.md) | not reported | [1.63](/filings/0000060086-26-000032.md) | [2.16](/filings/0000060086-26-000047.md) |
| Basic EPS | $ per share | [1.12](/filings/0000060086-24-000196.md) | not reported | [2.05](/filings/0000060086-25-000091.md) | [1.67](/filings/0000060086-25-000166.md) | [1.83](/filings/0000060086-25-000181.md) | not reported | [1.74](/filings/0000060086-26-000032.md) | [1.87](/filings/0000060086-26-000047.md) | [2.43](/filings/0000060086-25-000181.md) | not reported | [1.63](/filings/0000060086-26-000032.md) | [2.16](/filings/0000060086-26-000047.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.8](/filings/0000060086-23-000177.md) | [0.4](/filings/0000060086-25-000036.md) | [0.6](/filings/0000060086-24-000086.md) | [0.5](/filings/0000060086-24-000148.md) | [0.5](/filings/0000060086-24-000196.md) | [0.5](/filings/0000060086-26-000008.md) | [0.6](/filings/0000060086-25-000091.md) | [0.4](/filings/0000060086-25-000166.md) | [0.6](/filings/0000060086-25-000181.md) | [0.5](/filings/0000060086-26-000047.md) | [0.8](/filings/0000060086-26-000032.md) | [0.5](/filings/0000060086-26-000047.md) |
| Total assets | $bn | [76.5](/filings/0000060086-23-000177.md) | [79.2](/filings/0000060086-25-000036.md) | [80.9](/filings/0000060086-25-000091.md) | [81.1](/filings/0000060086-25-000166.md) | [83.6](/filings/0000060086-25-000181.md) | [81.9](/filings/0000060086-26-000008.md) | [83.1](/filings/0000060086-26-000032.md) | [84.7](/filings/0000060086-26-000047.md) | [85.9](/filings/0000060086-25-000181.md) | [86.3](/filings/0000060086-26-000047.md) | [85.7](/filings/0000060086-26-000032.md) | [87.2](/filings/0000060086-26-000047.md) |
| Total liabilities | $bn | [61.3](/filings/0000060086-23-000177.md) | [62.7](/filings/0000060086-25-000036.md) | [63.9](/filings/0000060086-24-000086.md) | [63.9](/filings/0000060086-24-000148.md) | [65.4](/filings/0000060086-24-000196.md) | [64.0](/filings/0000060086-26-000008.md) | [65.1](/filings/0000060086-25-000091.md) | [66.3](/filings/0000060086-25-000166.md) | [66.7](/filings/0000060086-25-000181.md) | [66.7](/filings/0000060086-26-000047.md) | [66.1](/filings/0000060086-26-000032.md) | [67.2](/filings/0000060086-26-000047.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [14.4](/filings/0000060086-23-000177.md) | [15.7](/filings/0000060086-25-000036.md) | [16.2](/filings/0000060086-24-000086.md) | [16.4](/filings/0000060086-24-000148.md) | [17.4](/filings/0000060086-24-000196.md) | [17.1](/filings/0000060086-26-000008.md) | [17.2](/filings/0000060086-25-000091.md) | [17.5](/filings/0000060086-25-000166.md) | [18.3](/filings/0000060086-25-000181.md) | [18.7](/filings/0000060086-26-000047.md) | [18.7](/filings/0000060086-26-000032.md) | [19.1](/filings/0000060086-26-000047.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,277 d](/filings/0000060086-24-000196.md) | [477 d](/filings/0000060086-26-000008.md) | [198](/filings/0000060086-25-000091.md) | [952 d](/filings/0000060086-25-000166.md) | [934 d](/filings/0000060086-25-000181.md) | [941 d](/filings/0000060086-26-000008.md) | [736](/filings/0000060086-26-000032.md) | [1,006 d](/filings/0000060086-26-000047.md) | [920 d](/filings/0000060086-25-000181.md) | [617 d](/filings/0000060086-26-000008.md) | [72.0](/filings/0000060086-26-000032.md) | [966 d](/filings/0000060086-26-000047.md) |
| Capital expenditure | $m | [164 d](/filings/0000060086-24-000196.md) | [223 d](/filings/0000060086-26-000008.md) | [159](/filings/0000060086-25-000091.md) | [159 d](/filings/0000060086-25-000166.md) | [140 d](/filings/0000060086-25-000181.md) | [174 d](/filings/0000060086-26-000008.md) | [98.0](/filings/0000060086-26-000032.md) | [134 d](/filings/0000060086-26-000047.md) | [156 d](/filings/0000060086-25-000181.md) | [191 d](/filings/0000060086-26-000008.md) | [204](/filings/0000060086-26-000032.md) | [258 d](/filings/0000060086-26-000047.md) |
| Dividends paid | $m | [14.0 d](/filings/0000060086-24-000196.md) | [14.0 d](/filings/0000060086-26-000008.md) | [14.0](/filings/0000060086-25-000091.md) | [14.0 d](/filings/0000060086-25-000166.md) | [14.0 d](/filings/0000060086-25-000181.md) | [13.0 d](/filings/0000060086-26-000008.md) | [13.0](/filings/0000060086-26-000032.md) | [13.0 d](/filings/0000060086-26-000047.md) | [13.0 d](/filings/0000060086-25-000181.md) | [13.0 d](/filings/0000060086-26-000008.md) | [13.0](/filings/0000060086-26-000032.md) | [13.0 d](/filings/0000060086-26-000047.md) |
| Share repurchases | $m | [116 d](/filings/0000060086-24-000196.md) | [140 d](/filings/0000060086-26-000008.md) | [24.0](/filings/0000060086-25-000091.md) | [179 d](/filings/0000060086-25-000166.md) | [59.0 d](/filings/0000060086-25-000181.md) | [346 d](/filings/0000060086-26-000008.md) | [394](/filings/0000060086-26-000032.md) | [257 d](/filings/0000060086-26-000047.md) | [55.0 d](/filings/0000060086-25-000181.md) | [100 d](/filings/0000060086-26-000008.md) | [31.0](/filings/0000060086-26-000032.md) | [154 d](/filings/0000060086-26-000047.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [241](/filings/0000060086-23-000177.md) | [234](/filings/0000060086-24-000086.md) | [228](/filings/0000060086-24-000148.md) | [226](/filings/0000060086-24-000196.md) | [223](/filings/0000060086-25-000091.md) | [222](/filings/0000060086-25-000166.md) | [220](/filings/0000060086-25-000181.md) | [213](/filings/0000060086-26-000032.md) | [209](/filings/0000060086-26-000047.md) | [208](/filings/0000060086-25-000181.md) | [206](/filings/0000060086-26-000032.md) | [206](/filings/0000060086-26-000047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 204,427,720 at 2026-07-31, from the cover of the [10-Q filed 2026-08-03](/filings/0000060086-26-000047.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.